Myruns has acquired 80% of the shares of Evolgene Genomics, a leading spin-off of the renowned cooperative nanoscience research center located in Guipuzcoa, CIC nanoGUNE.
Evolgene’s expertise lies in ancestral sequence reconstruction (ASR) to produce enzymes with extraordinary properties using ancestral cellulases and xylanases. The company has a portfolio of ancestral enzymes with a wide range of biotechnological and industrial applications. It has also developed a novel and innovative process to produce cellulose nanocrystals without the need to use hazardous chemicals. All this, together with its experience and in-depth knowledge of designing and selecting enzymes with improved properties, has made Evolgene a particularly attractive company in the technology development sector.
With this strategic acquisition, the main objective of both companies is to join forces to advance biomass treatment, the development of high value-added biomaterials and the creation of new generation biofuels, thus contributing to the production of clean and sustainable energy.
This collaboration is nothing new in the industry, as Evolgene and Myruns, as a company specializing in radio frequency technology (RFID), have already been working together for many years. company specializing in radio frequency (RFID) technology, have worked together on previous projectsWe have worked together on projects before, achieving exceptional results in technological development. Our collaboration has resulted in the registration of six revolutionary and successful patents, enabling the use of conductive inks in RFID tags, as well as the introduction of a highly disruptive technology never seen before: the replacement of metals with a conductive ink. These advances have far-reaching economic implications, as they can be applied in various sectors, such as cosmetics, pharmaceuticals and electronics.
This exciting step forward for science ensures a bright and promising future for both technologies, for innovation and for the advancement of the biotechnology industry.